David M. Bruggeman, President and Chief Operating Officer of Clinical Research Advantage, Inc. (CRA), was the recipient of two Stevie Awards at the 11th annual American Business Awards. Bruggeman received the Bronze Award for “Executive of the Year” in both the Pharmaceuticals and Health Products and Services categories.
Bruggeman was recognized for his ingenuity and leadership in building the country’s largest integrated network of clinical trial sites and partnering with Quintiles to create the first-ever therapeutic alliance for clinical trials in primary medicine. “David is an extraordinary leader whose work has improved the quality and efficiency of the clinical research process,” said Mark S. Hanley, CRA’s Chief Executive Officer. “We are happy to hear that David has received this national honor.”
The American Business Awards are the nation’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and private, for-profit and non-profit, large and small. Stevie Award winners were selected by more than 320 executives nationwide who participated in the judging process this year.
Nicknamed the Stevies for the Greek word for “crowned,” the awards were held on June 17th in Chicago, Illinois. This year, the judges reviewed more than 3,200 nominations from organizations of all sizes and virtually every industry.
